Cumberland Pharmaceuticals (CPIX) Reports Q4 Loss of $0.05

Cumberland Pharmaceuticals (NASDAQ: CPIX) reported Q4 EPS of ($0.05), versus $0.01 reported last year. Revenue for the quarter came in at $9 million, versus $7.89 million reported last year.

For earnings history and earnings-related data on Cumberland Pharmaceuticals (CPIX) click here.

You May Also Be Interested In

• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• Primoris cuts 2026 outlook on renewables cost overruns, COO exits
• Pfizer lung cancer drug misses survival goal in Phase 3 trial